Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2026-01-28 @ 2:30 PM
Study NCT ID:
NCT03940404
Status:
UNKNOWN
Last Update Posted:
2019-05-07
First Post:
2019-04-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anlotinib Therapy in Patients With Advanced Lung Cancer.
Sponsor:
First People's Hospital of Hangzhou
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ALOT-LC1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |